The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement
- 974 Downloads
Patients with type 2 diabetes mellitus have a higher risk of dental and/or orthopaedic implant failure. However, the mechanism behind this phenomenon is unclear, and animal studies may prove useful in shedding light on the processes involved. This review considers the available literature on rat models of diabetes and titanium implantation.
The process of osseointegration whereby direct contact is achieved between bone and an implant surface depends on healthy bone metabolism. Collective evidence suggests that hyperglycaemia adversely affects bone turnover and the quality of the organic matrix resulting in an overall deterioration in the quality, resilience and structure of the bone tissue. This in turn results in compromised osseointegration in patients receiving dental and orthopaedic implants. The incidence of diabetes mellitus (DM), which is a chronic metabolic disorder resulting in hyperglycaemia, is rising. Of particular significance is the rising incidence of adult onset type 2 diabetes mellitus (T2DM) in an ageing population. Understanding the effects of hyperglycaemia on osseointegration will enable clinicians to manage health outcomes for patients receiving implants. Much of our understanding of how hyperglycaemia affects osseointegration comes from animal studies.
In this review, we critically analyse the current animal studies.
Our review has found that most studies used a type 1 diabetes mellitus (T1DM) rodent model and looked at a young male population of rodents. The pathophysiology of T1DM is however very different to that of T2DM and is not representative of T2DM, the incidence of which is rising in the ageing adult population. Genetically modified rats have been used to model T2DM, but none of these studies have included female rats and the metabolic changes in bone for some of these models used are not adequately characterized.
Therefore, the review suggests that the study population needs to be broadened to include both T1DM and T2DM models, older rats as well as young rats, and importantly animals from both sexes to reflect more accurately clinical practice.
KeywordsAnimal models Implants Biochemical markers of bone turnover
A/Prof. Levinger was supported by Future Leader Fellowship (ID 100040) from the National Heart Foundation of Australia, and Dr. Brennan-Speranza was supported by an NHMRC Early Career Research Fellowship (ID 1013295).
Compliance with ethical standards
Conflict of interest
- 2.International Diabetes Federation. IDF Diabetes, 7th ed. Brussels, Belgium: International Diabetes Federation, 2015.www.diabetesatlas.org.Google Scholar
- 15.Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM (2003) Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. European journal of endocrinology / European Federation of Endocrine Societies 149(1):39–42CrossRefGoogle Scholar
- 19.Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, et al. (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8(2):260–270PubMedGoogle Scholar
- 21.Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, et al. (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism 95(11):5045–5055CrossRefGoogle Scholar
- 24.Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229.Google Scholar
- 31.Molon RS, Morais-Camilo JAND, Verzola MHA, Faeda RS, Pepato MT, Marcantonio E (2013) Impact of diabetes mellitus and metabolic control on bone healing around osseointegrated implants: removal torque and histomorphometric analysis in rats. Clin Oral Implants Res 24(7):831–837CrossRefPubMedGoogle Scholar
- 38.de Morais JA, Trindade-Suedam IK, Pepato MT, Marcantonio E Jr, Wenzel A, Scaf G (2009) Effect of diabetes mellitus and insulin therapy on bone density around osseointegrated dental implants: a digital subtraction radiography study in rats. Clin Oral Implants Res 20(8):796–801Google Scholar
- 40.Glösel B, Kuchler U, Watzek G, Gruber R (2010) Review of dental implant rat research models simulating osteoporosis or diabetes. International Journal of Oral & Maxillofacial Implants 25(3):516–524Google Scholar
- 68.Walder KR, Fahey RP, Morton GJ, Zimmet PZ, Collier GR (2000) Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Journal of Diabetes Research 1(3):177–184Google Scholar
- 69.Amir G, Adler J, Menczel J (1991) Histomorphometric analysis of weight bearing bones of diabetic and non-diabetic sand rats (Psammomys obesus). Diabetes research (Edinburgh, Scotland) 17(3):135–137Google Scholar
- 71.Storlien L, James D, Burleigh K, Chisholm D, Kraegen E (1986) Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. American Journal of Physiology-Endocrinology And Metabolism 251(5):E576–EE83Google Scholar
- 81.Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. (2016) Factors influencing early dental implant failures. J Dent ResGoogle Scholar